OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
GSM Eyes US, Europe Expansion Ahead of 2028 Hong Kong IPO 
OpenAI Rejects Apple Trade Secret Theft Claims 
Microsoft to Reveal Azure Revenue in Major Reporting Shake-Up 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Adobe Names Anil Chakravarthy CEO as AI Push Accelerates 
Anthropic Nears $15 Billion Credit Deal Ahead of IPO 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
MongoDB Stock Sinks 14% as Atlas Growth Misses Expectations 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Add as a preferred source on Google
PLANO, Texas, March 06, 2018 -- The Pharmacy Benefit Management Institute (PBMI) will present eight organizations with a 2018 Excellence Award during its 23rd Annual National Drug Benefit Conference today in Palm Springs, California. This award program recognizes exceptional contributions across the pharmacy management landscape in the areas of Care Management Strategies, Cost Containment, and Quality Improvement. This year, in recognition of efforts to curb the opioid epidemic, PBMI created a special Excellence Award honoring organizations demonstrating excellence in Opioid Management Strategies.
“Opioid abuse has become a nationwide issue with staggering statistics affecting millions of people across our country,” says Jane Lutz, Executive Director of PBMI. “We are pleased this year to add a new award category to recognize organizations implementing creative solutions to combat this significant problem.”
The following highlights the organizations that will be awarded in each category:
Care Management Strategies
- CVS Health is recognized for its ScriptPath™ Prescription Schedule tool.
- Southwest Airlines is recognized for the results achieved by combining the evidence-based approach of a specialty management program with their oncology program to implement a split fill program for 19 oncology drugs.
- Texas Oncology is recognized for the success of its Medically Integrated Pharmacy Care model.
Cost Containment
- HealthPartners is recognized for its mandatory Site of Care Program.
Quality Improvement
- Abarca is recognized for the improvements it helped achieve in medication therapy management (MTM) and comprehensive medication review (CMR) performance for a Medicare Part D health plan.
- PersonalMed is recognized for its pharmacy certification (cCert) credentialing program.
Opioid Management Strategies
- Express Scripts is recognized for its Advanced Opioid Management Solution which manages new and acute opioid users, short-term or intermittent opioid users, patients on long-term/chronic opioid therapy, as well as those patients who may be overusing or abusing opioids.
- Prime Therapeutics is recognized for its Controlled Substance Management Program. This program includes several components which work in concert to identify and target individuals at risk of misusing controlled substances.
To learn more about these organizations’ programs/approaches, click here.
About PBMI
The Pharmacy Benefit Management Institute is dedicated to unraveling the complexities of pharmacy benefit management by providing research, continuing education, and Web resources that help organizations work effectively with their pharmacy benefit managers to improve the overall management of drug benefit programs. Learn more at www.pbmi.com.
Contact:
Julie Blackman
PBMI
480-730-0814
[email protected]
